RSVP For Part I

RSVP For Part II

Did you know that approximately 75% of strokes occur in people aged 65 or older? 

Join Kensington Senior Living and leading neurology specialists for a 2-part panel discussion on June 23^rd and July 20^th, to address stroke warning signs, latest research, prevention measures, innovations in treatment, the process of recovery, holistic approaches to healing, and life after a stroke.

Gain expert insight from renowned specialists, Neil Schwartz & Christina Mijalski Sells, Stanford, Matthew Edwardson, Georgetown, Lucas Restrepo, UCLA, & Atrac Aryan Kay, INOVA, and have your questions answered.

At Kensington Senior Living, our mission to improve and preserve the quality of life for every resident is a collaborative effort. To that end, we have built strong relationships with expert professionals who keep us current with the latest advances in care, management and treatment of conditions that affect seniors and their families.

Our Promise at The Kensington is to love and care for your family as we do our own. And we do. We are here for you – skilled, prepared and ready to participate fully in your care journey. As specialists in all aspects of care both Assisted Living and Memory Care, we offer services and programs that are thoughtfully designed, clinically comprehensive and highly personalized. We improve quality of life for our residents to the greatest extent possible. We’re standing by, eager to listen and ready to help.

For questions regarding this event, please email Amber Brooksher, Director of Sales & Marketing, abrooksher@kensingtonsl.com.

Meet The Presenters

Neil Schwartz, MD, PhD completed his undergraduate studies at UCLA, followed by MD and PhD degrees at Northwestern University. After his Neurology residency at Stanford, Dr. Schwartz joined the Stanford Stroke Center in 2004 as a fellow in Vascular Neurology and has remained on as faculty since 2007. Currently, his primary focus is the care of patients with cerebrovascular disease in both the inpatient and outpatient setting, including patients with both ischemic and hemorrhagic strokes. He has a particular interest and expertise in cervical artery dissection, non-atherosclerotic vasculopathies, stroke in young adults, and stroke recovery trials utilizing stem cells. Dr. Schwartz is a national leader in neurological education and served as the Program Director for the Stanford Neurology Residency Program for nearly a decade, but remains involved as the Associate Program Director, and Vice Chair (Education). He also serves as the Medical Director for inpatient Neurology (L5) at Stanford HealthCare. He is the director of the Young Stroke Program within the Stanford Stroke Center.

Christina Mijalski Sells, MD, MPH is a Clinical Assistant Professor, Neurology & Neurological Sciences at Stanford.

Dr. Atrac Aryan Kay, MD is a Neurologist specializing in Neurology (Brain & Spinal Cord Disease). He graduated from Ross University School of Medicine. Dr. Atrac Aryan Kay, MD is affiliated with Inova, Inova Fair Oaks Hospital, Southern Regional Medical Center, Inova Alexandria Hospital, Inova Fairfax Hospital and Inova Medical Group.

Matthew A. Edwardson, MD is a vascular neurologist whose research explores the biological mechanisms behind recovery after brain injury in humans.  His interests include the mechanisms of neural repair induced by the brain injury itself as well as those brought about through neurorehabilitation strategies.  He primarily studies patients with stroke and focuses on the early phase after injury, a time that may represent a “critical period” during which the brain is better able to learn new skills.  He uses multi-omic evaluation of blood samples, including metabolomics, to identify molecular changes that signal neural injury and repair in the brain.  Dr. Edwardson also studies recovery using neuro-imaging techniques such as MRI and DTI.

Lucas Restrepo, MD, PhD obtained his MD degree from the Health Science Institute in Colombia, South America in 1993, completing his neurology residency at Georgetown University in 2000 and a stroke fellowship at Johns Hopkins Hospital with Robert J. Wityk in 2002. He has earned several academic awards, including “intern of the year” at the University of Texas Health Science Center in San Antonio in 1996 and being named “neurology attending of the year” by the UCLA neurology residents in 2006 and 2010. He earned a PhD in Molecular and Cell Biology at Arizona State University in 2011 under the mentoring of Stephen Albert Johnston. Dr. Restrepo has published over 40 peer-reviewed papers, some with relevant impact. Two of his papers about advanced MRI techniques and transcranial Doppler ultrasound for the evaluation of the pathophysiology of brain ischemia were selected as “best paper (s) published in the Journal of Neuroimaging” for 2 consecutive years (2003 and 2004). Dr. Restrepo is co-inventor of several cooling devices for neuroprotection and helped develop a blood test for Alzheimer’s Disease. He is currently a Clinical Associate Professor of Neurology at the David Geffen School of Medicine at UCLA.